How much dividend does Somalogic pay?
Over the past 12 months, Somalogic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Somalogic is expected to pay a dividend of 0 USD.
Somalogic Dividend 2025
Somalogic Dividend
0 USD
Somalogic Dividend yield
Ticker
SLGC
ISIN
US83444K1051
WKN
A3C14K
How much dividend does Somalogic 2025 pay?
According to the latest status from June 2025, Somalogic paid a total of 0 USD per share in dividends within the last 12 months. With the current Somalogic price of 2.1 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.
| = |
Historical Somalogic Dividends
A dividend is paid times per year. Last year, the payout months were and .
| Paydate | Dividend |
|---|
Is the Somalogic Dividend Safe?
Somalogic has been increasing the dividend for 0 years.
Over the past 4 years, Somalogic has increased it by an annual 0 %.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
Dividend Details
Understanding Somalogic's Dividend Distributions
Somalogic’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining Somalogic's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
Somalogic's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in Somalogic’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
Somalogic Aktienanalyse
What does Somalogic do?
SomaLogic Inc is a diagnostic biotech company specializing in a new way of clinically diagnosing diseases. It was founded in 2000 by Larry Gold, a renowned researcher and pioneer in the field of molecular diagnostics. The idea behind Somalogic arose from the need to bridge the gap between clinical needs and conventional diagnostic methods. SomaLogic's business model can be described as a service provider and licensee. The company offers its customers a wide range of products and services, from technology development to clinical disease diagnosis. The model is based on Somalogic's unique ability to measure a large number of proteins simultaneously, thus creating a comprehensive picture of their biological activity. The spheres of Somalogic encompass three main areas: proteins, data, and biomedicine. The protein sphere refers to Somalogic's core competence in the field of proteomics. The company has developed a proprietary technology that allows for the measurement of up to 5000 proteins in a single sample. Somalogic's technology is based on a special sample format called "SOMAScan," which utilizes proprietary aptamer technology to achieve ultra-high protein molecular signature accuracy. Somalogic's data sphere is deeply rooted in both the protein sphere and the biomedicine sphere. The company has a proprietary database that encompasses thousands of proteins. This database is continuously updated and expanded to provide increasingly robust quantitative protein data. The database enables Somalogic to identify and validate specific protein signatures associated with diseases. Somalogic also utilizes machine learning and artificial intelligence tools to take the interpretation of this data to the next level. The biomedicine sphere of Somalogic is the area where the company brings its diagnostic and therapeutic developments to the market. Somalogic works closely with pharmaceutical companies and clinical laboratories to develop clinical diagnostic tests based on its proprietary technology. The company has generated valid clinical data on a range of diseases and demonstrated the ability to identify biomarkers specifically associated with certain diseases. In its business development, Somalogic has created and licensed a wide range of products. The company has successfully formed partnerships with a number of companies and institutions to provide both proteomics tools and services. Some notable examples include partnerships such as collaboration with Biogen in the development of diagnostic tools for multiple sclerosis and other neurological disorders. Another example of Somalogic's product range is the successful collaboration with the New York State Health Department, where the company used its technology to investigate the SARS-CoV-2 virus. In this context, Somalogic generated information about specific biomarkers for COVID-19 and other masked and bound viral diseases. SomaLogic has the potential to change the way diseases are diagnosed and therapeutically treated. The company is on a path to revolutionize the diagnostic capabilities of the healthcare system and leave its mark on the healthcare market. Somalogic is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Frequently Asked Questions about Somalogic stock
What is the dividend yield of Somalogic?
The current dividend yield of Somalogic is .
When does Somalogic pay dividends?
Somalogic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Somalogic?
Somalogic paid dividends every year for the past 0 years.
What is the dividend of Somalogic?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Somalogic located?
Somalogic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Somalogic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Somalogic from 6/24/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/24/2025.
When did Somalogic pay the last dividend?
The last dividend was paid out on 6/24/2025.
What was the dividend of Somalogic in the year 2024?
In the year 2024, Somalogic distributed 0 USD as dividends.
In which currency does Somalogic pay out the dividend?
The dividends of Somalogic are distributed in USD.
Andere Kennzahlen von Somalogic
Our stock analysis for Somalogic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Somalogic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.